flecainide acetate oral inhalation solution (FlecIH-103) / InCarda  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
flecainide acetate oral inhalation solution (FlecIH-103) / InCarda
INSTANT, NCT03539302 / 2018-000094-76: INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm

Completed
2
176
Europe
Flecainide Acetate, FlecIH
InCarda Therapeutics, Inc.
Paroxysmal Atrial Fibrillation (PAF)
01/22
01/22

Download Options